Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
17.93
-0.29 (-1.59%)
At close: Feb 20, 2026, 4:00 PM EST
17.98
+0.05 (0.28%)
After-hours: Feb 20, 2026, 7:34 PM EST

Eton Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
48135511271106197
Market Cap Growth
-1.08%215.68%57.54%-32.42%-46.38%53.54%
Enterprise Value
475339966490197
Last Close Price
17.9313.324.382.824.298.13
Forward PE
32.4157.9179.64-9.98-
PS Ratio
6.849.093.553.364.845047.59
PB Ratio
20.7914.527.265.465.9912.57
P/TBV Ratio
--10.478.577.5413.05
P/FCF Ratio
22.88376.2216.4914.92--
P/OCF Ratio
22.56366.1316.4914.80--
EV/Sales Ratio
6.758.693.043.034.115040.62
EV/FCF Ratio
22.58359.3214.1113.46--
Debt / Equity Ratio
1.341.230.350.500.380.46
Debt / FCF Ratio
1.4731.810.801.36--
Net Debt / Equity Ratio
-0.270.62-1.03-0.75-0.44-0.90
Net Debt / EBITDA Ratio
-1.32-13.6144.511.496.880.53
Net Debt / FCF Ratio
-0.3015.97-2.34-2.041.630.63
Asset Turnover
1.000.721.120.810.810.00
Inventory Turnover
3.251.9314.4212.533.160.54
Quick Ratio
1.141.021.532.814.365.63
Current Ratio
1.632.061.653.105.186.51
Return on Equity (ROE)
-34.17%-19.16%-6.56%-58.75%-11.74%-213.40%
Return on Assets (ROA)
1.26%-2.53%-2.63%-19.67%-3.47%-78.10%
Return on Capital Employed (ROCE)
2.30%-3.90%-7.70%-44.50%-6.50%-120.40%
Earnings Yield
-1.39%-1.08%-0.83%-12.65%-1.85%-14.21%
FCF Yield
4.37%0.27%6.06%6.71%-4.48%-11.38%
Buyback Yield / Dilution
-3.52%-0.97%-1.99%0.24%-19.98%-18.30%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q